HCID 19017496, compound → HCID 10481928, compound
Reaction equation
CC([O:5][C:6](=[O:42])[CH:7]([NH:25][CH:26]([C:31]([NH:33][CH2:34][CH2:35][N:36]1[CH2:41][CH2:40][O:39][CH2:38][CH2:37]1)=[O:32])[CH2:27][CH:28]([CH3:30])[CH3:29])[CH2:8][CH2:9][N:10]1[C:18](=[O:19])[C:17]2[CH:16]=[C:15]3[CH:20]=[CH:21][CH:22]=[CH:23][C:14]3=[CH:13][C:12]=2[C:11]1=[O:24])(C)C>C(O)(C(F)(F)F)=O>[O:24]=[C:11]1[C:12]2[CH:13]=[C:14]3[CH:23]=[CH:22][CH:21]=[CH:20][C:15]3=[CH:16][C:17]=2[C:18](=[O:19])[N:10]1[CH2:9][CH2:8][C@@H:7]([NH:25][C@H:26]([C:31]([NH:33][CH2:34][CH2:35][N:36]1[CH2:41][CH2:40][O:39][CH2:38][CH2:37]1)=[O:32])[CH2:27][CH:28]([CH3:30])[CH3:29])[C:6]([OH:42])=[O:5]Participants
3
Reactant 1
Product 1
Reagents, catalysts & solvents 1
Procedure
240 mg of 4-(1,3-dihydro-1,3-dioxo-2H-benz[f]isoindol-2-yl)-2-[[3-methyl-1-[[(2-morpholin-4-yl-ethyl)amino]carbonyl]butyl]amino]-butanoic acid-1,1-dimethylethyl ester from part (A), was dissolved in TFA:H20 (9:1) and allowed to stand for 20 h. The solvents were removed by evaporation, and the resulting oil was purified by reverse phase H.P.L.C. The solvents were removed by lyopholization to give the title compound as a white solid; 145 mg.
Workup
- customThe solvents were removed by evaporation
- customthe resulting oil was purified by reverse phase H.P.L.C
- customThe solvents were removed by lyopholization
Sources & evidence
- ORD record
- ord-18fbfe8340ed4d06aa50cc99352cb1a6
- Source dataset
- uspto-grants-1994_07
- Patent number
- US05326760
Reaction notes
Loading…